Rocket Pharmaceuticals (RCKT) Research & Development (2014 - 2026)
Rocket Pharmaceuticals' Research & Development came in at $29.5 million for Q2 2026, down 30.9% from $42.66 million a year earlier and down 6.2% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Research & Development (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Rocket Pharmaceuticals reported Research & Development of $124.37 million, down 21.4% year-over-year; for FY2025, it was $142.02 million, down 17.1% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $171.24 million in FY2024 (-8.1%), $186.34 million in FY2023 (+12.5%), $165.57 million in FY2022 (+32.0%) and $125.48 million in FY2021 (+19.0%).
- The five-year range for quarterly Research & Development is $29.35 million (Q4 2025) to $51.38 million (Q2 2023).
- Year-over-year, Research & Development has declined for 11 consecutive quarters, with an average decline of 16.6% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 82.9%), and the weakest in Q4 2021 (a decline of 34.1%).
- Business Quant data shows RCKT's Research & Development at $31.45 million (Q1 2026), $29.35 million (Q4 2025) and $34.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Rocket Pharmaceuticals | 258.98 Mn | -24.72 Mn | - | 29.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.50 Mn |
| Mar 31, 2026 | 31.45 Mn |
| Dec 31, 2025 | 29.35 Mn |
| Sep 30, 2025 | 34.07 Mn |
| Jun 30, 2025 | 42.66 Mn |
| Mar 31, 2025 | 35.94 Mn |
| Dec 31, 2024 | 37.36 Mn |
| Sep 30, 2024 | 42.32 Mn |
| Jun 30, 2024 | 46.35 Mn |
| Mar 31, 2024 | 45.23 Mn |
| Dec 31, 2023 | 41.74 Mn |
| Sep 30, 2023 | 46.84 Mn |
| Jun 30, 2023 | 51.38 Mn |
| Mar 31, 2023 | 46.37 Mn |
| Dec 31, 2022 | 50.04 Mn |
| Sep 30, 2022 | 43.38 Mn |
| Jun 30, 2022 | 41.36 Mn |
| Mar 31, 2022 | 30.79 Mn |
| Dec 31, 2021 | 33.02 Mn |
| Sep 30, 2021 | 39.62 Mn |
API Access
Rocket Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();